Medikit Co.,Ltd. (TYO:7749)

Market Cap	44.32B +15.3%
Revenue (ttm)	23.19B +4.0%
Net Income	3.09B +1.9%
EPS	210.70 +6.8%
Shares Out	14.63M
PE Ratio	14.38
Forward PE	n/a
Dividend	100.00 (3.31%)
Ex-Dividend Date	Mar 30, 2026

Volume	3,500
Average Volume	2,885
Open	3,030.00
Previous Close	3,030.00
Day's Range	3,000.00 - 3,030.00
52-Week Range	2,362.00 - 3,095.00
Beta	0.10
RSI	59.29
Earnings Date	Feb 12, 2026

About Medikit

Medikit Co.,Ltd., together with its subsidiaries, develops, manufactures, sells, and exports medical devices related to blood vessels and blood in Japan and internationally. The company offers IV catheters, such as Supercath 5 and Supercath Ztu-V; hemodialysis products, including Supercath PRO, Supercath NEO, and Supercath Clampcath; and intervention products comprising Supersheath sheath introducers and Mongoose angiography catheters. It also provides indwelling needles for artificial dialysis; and needles for blood transfusions and infusions....

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1973
• Employees: 989
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 7749

Financial Performance

In fiscal year 2025, Medikit's revenue was 22.55 billion, an increase of 3.22% compared to the previous year's 21.85 billion. Earnings were 3.01 billion, a decrease of -1.82%.